Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00063
Species: Homo sapiens
Position : chr8:128821774-128822358
Year: 2018
Title: Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast cancer
PMID:  29731168
MONDO: MONDO:0007254
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MDA-MB-231
CVCL ID: CVCL_0062
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; Functional perturbation assay; Chromatin interaction assay; Promoter-enhancer competition assay; Endogenous enhancer perturbation; Disease-variant functional analysis; In vivo functional validation
High Throughput Method: H3K27ac HiChIP
Low Throughput Method: CRISPRi; UMI-4C; Luciferase Reporter Assay; qRT-PCR; ChIP-qPCR; CRISPR-Cas9 endogenous deletion/editing; In vivo phenotyping
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_02292 chr8:128750000-129000000 breast malignant cell prostate cancer
E_00375 chr8:128821500-128822500 breast breast carcinoma epithelial cell breast carcinoma
E_00459 chr8:128821500-128822500 breast malignant cell breast carcinoma
Expression of Target Genes for the Enhancer